Principal Investigator: Shan X. Wang (Project 4 Leader)

Sponsor: NIH

The Center hypothesizes that multi-scale measurement and modeling will allow specific cases of cancer to be modeled with sufficient fidelity to estimate the relative probable efficacy of alternative therapies. In particular, Wang group is applying magneto-nano chip to follow cancer therapy responses in animal models relevant to lymphoma, acute myeloid leukemia (AML), and lung cancer.